Atlas Trials

Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia

Clinical trial NCT01373281 · COMPLETED

Trial details

NCT number
NCT01373281
Sponsor
Sanofi Pasteur, a Sanofi Company
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
DengueDengue FeverDengue Hemorrhagic Fever
Start date
2011-06-03
Primary completion
2014-08-01
Enrollment
10275

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.